The Wyss Institute at Harvard University
@wyssinstitute.bsky.social
1K followers 89 following 280 posts
The Wyss Institute seeks to transform engineering, medicine and the environment by creating new materials and devices using Nature’s design principles.
Posts Media Videos Starter Packs
wyssinstitute.bsky.social
Wyss researchers developed ReConstruct, an approach that creates living tissue implants from a patient's own cells that can be integrated into their body to offer cancer survivors a more natural, safer reconstruction option following a mastectomy. #BreastCancerAwarenessMonth
ReConstruct: Vascularized Tissue for Breast Reconstruction and Augmentation
ReConstruct is a platform for growing, vascularizing, and implanting patient-derived tissues that enable safer breast reconstruction after cancer surgery.
wyss.harvard.edu
wyssinstitute.bsky.social
We are looking for a Senior Manager of Donor Relations to strategically grow and manage a growing portfolio of new prospects and donors. In this role, you will be a key contributor to expanding the donor base and strengthening stewardship practices that align with the Institute’s strategic goals.
Senior Manager, Donor Relations
We are looking a Senior Manager of Donor Relations to partner closely with the Director of Strategic Engagement to strategically grow and manage a growing portfolio of new prospects and donors. In thi...
wyss.harvard.edu
wyssinstitute.bsky.social
Sepsis is a life-threatening condition, & the third leading cause of neonatal mortality worldwide. Current sepsis diagnostics rely on blood draws that can take days to deliver results.

So, Wyss researchers are developing Neosense, a faster & more accurate method for diagnosing sepsis using saliva.
NeoSense: Sepsis Detection in Newborns
NeoSense is a new test that uses a tiny sample of saliva instead of blood, powered by advanced single-molecule detection and AI.
wyss.harvard.edu
wyssinstitute.bsky.social
The HarborSite platform overcomes key limitations in current gene therapy approaches by combining two genome editing technologies: genomic safe harbors and highly effective recombinases. Combined, these could enable more predictable, safe, and durable future gene therapies.
HarborSite: Precise and Efficient Gene Editing for Next-Generation Gene Therapies
The HarborSite next-generation gene therapy platform enables integration of therapeutic genes into genomic safe harbors using highly specific and efficient recombinases to enable more predictable,…
buff.ly
wyssinstitute.bsky.social
Our team is developing injectable immune organs (iNodes) that aim to boost immune responses to enable the formation of lymphoid organs and improve ovarian cancer survival rates by at least 50%. This innovative approach may also benefit other cancers and diseases.
iNode: Implantable Lymphoid Organs for Ovarian Cancer Therapy
Over 12,000 women die of ovarian cancer every year, yet ovarian cancer receives less than 1% of research funding compared to other solid tumors. Early symptoms can often mimic less serious…
buff.ly
wyssinstitute.bsky.social
In this podcast interview, the Wyss' Peter Nguyen explores how synthetic biology can turn biofilms into useful materials, embed cell-free systems into wearables, & program probiotics as future therapeutics. He discusses the philosophy behind bioengineering, iGEM, & ideas to tackle plastic pollution.
Engineering Living Materials with Peter Q. Nguyen
In this episode of the CoreSpin Podcast Interview Series, host Misha Bagirov sits down with Wyss Senior Scientist Peter Q. Nguyen, Ph.D., to explore how synthetic biology can turn biofilms into…
buff.ly
Reposted by The Wyss Institute at Harvard University
scienceinboston.com
🩸 The @wyssinstitute.bsky.social has received Wellcome Leap funding to develop the first-ever human Organ Chip model for heavy menstrual bleeding. This work led by Dr. Don Ingber could transform our understanding of #ReproductiveHealth and lead to better treatments.

See more: https://bit.ly/3KBzcGe
wyssinstitute.bsky.social
With funding from Wellcome Leap, the Wyss will develop the first human model of HMB enabling researchers to uncover the causal factors & early biomarkers of HMB progression & identify potential non-hormonal therapeutics by combining multi-omics analysis w/ AI-driven computational approaches.
Wyss Institute receives Wellcome Leap funding to develop first Human Organ Chip model for heavy menstrual bleeding
By Alexandra Jirstrand (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap’s $50 million The Missed Vital Sign…
buff.ly
wyssinstitute.bsky.social
The GeneSkin team is developing breakthrough mRNA therapies that focus on restoring the function of basal skin stem cells by reducing inflammation and mitigating cellular stress, which is critical for skin rejuvenation and hair restoration.
GeneSkin: A Novel mRNA Therapy for Skin and Hair Rejuvenation
GeneSkin is developing novel mRNA therapies to rejuvenate skin and hair by targeting basal stem cells. Using advanced microneedle delivery, our non-invasive treatments aim to reduce scarring, reverse ...
wyss.harvard.edu
wyssinstitute.bsky.social
In this paper in @cp-patterns.bsky.social, Core Faculty member George Church, Postdoc Li Li, and their colleagues outline how LLMs are becoming crucial tools at every stage of drug development to dramatically reduce the time and cost associated with bringing new therapeutics to patients.
Large language models for drug discovery and development
In this review, the authors explore the transformative impact of large language models (LLMs) on drug discovery and development. They detail how LLMs can potentially accelerate our understanding of…
buff.ly
wyssinstitute.bsky.social
Check out this collection of short dispatches from the field of climate microbiology from @quantamagazine.bsky.social, which includes a conversation with Core Faculty member Pam Silver on her vision of engineering microbes that can make carbon-based products and replace the fossil fuel economy.
Microbes Also Change the Climate. Could That Help Us? | Quanta Magazine
A collection of short dispatches from the field of climate microbiology conveys the contributions that single-celled life forms make to our climate system, and how we can work with them to address cli...
www.quantamagazine.org
wyssinstitute.bsky.social
How can we better harness immune cells to treat disease?

Cellular "backpacks," developed at the Wyss, are disc-shaped nanoparticles that can stick to immune cells without being engulfed, and keep them activated against diseases, including cancer and autoimmune diseases.
Cellular “Backpacks” to Fight Cancer, Autoimmune Disorders, and More
Macrophages are very malleable immune cells, but that also means that they can be influenced by cancerous tumors and inflammatory processes. Our cellular "backpacks" stick to macrophages and can…
buff.ly
wyssinstitute.bsky.social
The Ichor project uses multiomics and gene network data to identify genes that can reverse the biological age of distinct human cell types. It has the potential to treat major age-related diseases, including cardiovascular disease, neurodegeneration, and cancer.
Ichor: Reversing Aging
Ichor is addressing multiple age-related diseases by identifying genetic interventions that reprogram old cells to a younger state. Therapies based on these interventions could improve survival for…
buff.ly
wyssinstitute.bsky.social
What does it take to transform an innovative idea at the bench into a commercializable product that can overcome the valley of death and make a positive societal impact? The Wyss' in-house Business Development Team knows the answers. Learn more about the team and how they support the Wyss community.
Mentoring and making connections: Business Development Team spotlight
By Jessica Leff Imagine you’re a researcher who has answered pressing scientific questions and overcome challenges to develop an innovative way to detect pathogens. In addition to technical feasibilit...
wyss.harvard.edu
wyssinstitute.bsky.social
As we #ReimagineTheWorld without terminal cancer and work towards that vision, we keep patients like Wyss Scientific Instrument Maker John Caramanica, who continues working even after being diagnosed with metastatic skin cancer, at the top of our minds. #WorldCancerResearchDay
Reimagining the World Without Terminal Illness: John Caramanica
By Jessica Leff  As he battles metastatic skin cancer, Wyss Scientific Instrument maker John Caramanica is more motivated than ever to do his part in fabricating technologies to improve the health of ...
wyss.harvard.edu
wyssinstitute.bsky.social
Lorenzo Ferri's group at McGill, in collaboration with Don Ingber, developed patient-specific organs-on-chips that accurately predicted how cancer patients responded to different chemotherapy regimens. Their study opens up exciting new possibilities for drug discovery and precision oncology.
An organ chip that predicts the response to chemotherapy | McGill University Health Centre
With the development of a patient-specific organ-on-a-chip, Dr. Lorenzo Ferri at The Institute and collaborators at Harvard are advancing personalized cancer medicine.
buff.ly
wyssinstitute.bsky.social
Yesterday, Wyss researchers volunteered at the Cambridge Science Carnival, a family-friendly science extravaganza, where they taught curious minds of all ages about Organ Chips.
Six people standing behind a table; they're holding stickers and display items and there is a projector and microscope on the table Two people standing behind a table as a young boy holds on to a microscope, about to look in A woman pointing to a large-scale model of an Organ Chip A woman gesturing towards a large-scale model of an Organ Chip
wyssinstitute.bsky.social
Namita Sarraf loves to find herself at intersections. As a Wyss postdoc, she's pursuing interests in technology and business development. She's working on two DNA nanotechnology projects while also co-leading the Biotech Interest Group. Learn more about Namita and her work in this month’s #HOWyss.
Namita Sarraf on Using DNA as a Building Block
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and be...
wyss.harvard.edu
wyssinstitute.bsky.social
"We're thinking about any way we can get this to patients. That's the whole point of what we're trying to do," explains Paul Stankey, a researcher in Core Faculty member Jennifer Lewis' lab. Learn what it will take to scale up their work and bring their technologies to patients.
Boston’s Additive Edge: Inside Harvard’s Lewis Lab and the Road to Patients, Part II - 3DPrint.com | Additive Manufacturing Business
When I visited Jennifer Lewis’s lab earlier this summer, doctoral researcher Paul Stankey showed me how the team is laying the groundwork for bioprinting, from stem cells to vascular networks...
3dprint.com
wyssinstitute.bsky.social
Happy #PostdocAppreciationWeek!

Our driven, hardworking, creative postdocs power our engine of innovation towards positive impact. We celebrated these individuals with a lunch, complete with messages of gratitude from across the Institute. Thank you!
Four people sitting at a table smiling, with empty dishes and soda cans in front of them Someone standing and talking into a mic Two people sitting at a table and smiling Five people sitting at a table with empty dishes and soda cans in front of them
wyssinstitute.bsky.social
Because of the success of the composting program at the Wyss, initiated by our Green Team, and a few other tenant companies, our building is instituting compost collection for everyone to enable all of our work neighbors to prevent pollution and live more sustainably. #PollutionPreventionWeek
Text says, “Since moving into our new habitat in the fall of 2023.” There is a graphic of a trash can, and bold text says, “6,240 pounds of food waste diverted,” then regular text says, “through our composting program.”